1.1. Background: Chronic kidney disease is one of the most significant complications after liver transplant. Materials and Methods:We included in this study 151 of 206 patients transplanted from March 2000 to March 2016 in the Liver Transplant Service at the Guillermo Almenara National Hospital (EsSalud) Lima-Peru, and had been alive with follow up for at least 3 months after liver transplantation: 98 males (64.9%), 53 females (35.1%); mean age, 49.9 years; age range, 18-77 years. Updated data were collected regarding age, sex, body mass index, underlying liver disease, graft type, immuno suppressive treatment, MELD score, last serum creatinine levels in the outpatient clinic follow up, and glomerular filtration rate (GFR) at 1,3,5,10 and > 10 years after liver transplant. GFR was calculate for 2 methods: CKD-EPI and MDRD4. Data were analyzed with SPSS software version 25.0. Results:The mean follow-up was 60.1 months (range, 3-192 months). The main indications for liver transplantation were: Metabolic associated fatty liver disease (